Moderna, Inc. MRNA

198.88 4.06 2.08% as of 25 Sep
Market cap
$78.8B
P/E
0.0×
Indexes indicate stock being part of an index
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 8.39 8.47 0.00 0.00 0.00
P/S ratio
0.00 0.00 9.17 107.91 49.57 5.54 3.66 6.28 4.93 5.90
P/FCF ratio
0.00 0.00 0.00 0.00 20.32 7.68 15.39 0.00 0.00 0.00
P/Operating CF
(15.37) (15.37) (13.61) (65.36) 31.49 30.92 42.43 69.09 19.35 12.34
P/B ratio
0.00 0.00 0.81 5.51 15.54 7.24 3.69 3.10 1.46 1.33
Price to Tangible BV
0.00 0.00 0.81 5.51 15.54 7.24 3.69 3.12 1.48 1.34
EV/Sales
0.00 0.00 (2.10) 90.15 43.97 4.99 3.19 5.10 2.78 3.23
EV/EBITDA
0.00 0.00 0.73 0.00 0.00 6.79 6.28 0.00 0.00 0.00
EV/Operating CF
(0.83) (0.83) 0.86 (11.78) 17.42 6.77 12.35 (11.21) (2.99) (3.35)
EV/FCF
(0.66) (0.66) 0.65 (11.02) 18.02 6.92 13.43 (9.14) (2.21) (3.03)
Quick Ratio
6.58 4.02 6.89 7.75 1.37 1.52 2.29 3.15 3.35 3.01
Current Ratio
6.68 4.09 7.02 7.89 1.44 1.76 2.73 3.42 3.67 3.29
Net Debt/EBITDA
5.07 2.99 3.82 2.05 6.23 (0.75) (0.92) 2.18 1.81 1.77
Debt/Assets
0.92% 1.48% 1.68% 2.43% 1.50% 2.43% 3.53% 3.12% 0.28% 4.94%
Debt/Equity
(0.04) (0.03) 0.02 0.03 0.04 0.04 0.05 0.04 0.00 0.07
Asset Turnover
0.09 0.16 0.09 0.03 0.18 1.15 0.76 0.31 0.20 0.15
Operating CF/Net income
(0.29) 1.23 0.82 0.89 (2.71) 1.12 0.60 0.66 0.84 0.66
Capex/Depreciation
(1.88) (2.70) (4.60) (1.19) (1.66) (0.99) (1.06) (1.26) (11.18) (1.36)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
52.00% 60.90% (82.11%) (38.00%) (39.99%) 146.08% 50.27% (28.59%) (28.77%) (28.87%)
ROA
(18.42%) (21.57%) (26.38%) (28.94%) (16.74%) 76.25% 33.10% (21.29%) (21.87%) (21.31%)
ROIC
0.00% 0.00% (626.63%) (311.74%) 0.00% 206.87% 58.10% (45.48%) (62.98%) (55.51%)
Return on Tangible Assets
(22.90%) (36.92%) (25.89%) (43.30%) (33.86%) 149.10% 79.44% (50.93%) (44.02%) (42.18%)
Average Days of Receivables
45.54 23.79 34.01 32.66 632.27 62.74 26.24 47.54 40.38 34.55
Research and Development Expense of Revenue
253.44% 199.42% 336.19% 826.67% 170.61% 10.78% 17.11% 70.75% 140.39% 161.11%
Selling, General and Administrative Expense of Revenue
53.00% 31.45% 69.78% 183.33% 23.41% 3.07% 5.88% 22.62% 36.28% 52.37%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
36.31% 19.46% 53.72% 135.00% 11.58% 0.77% 1.17% 4.45% 13.26% 24.85%
Graham Net Nets
0.64 0.64 0.91 0.11 0.04 0.05 0.09 0.13 0.30 0.25
Graham Number
0.00 0.00 0.00 0.00 0.00 154.64 151.90 0.00 0.00 0.00
Earnings Yield
(14.03%) (14.03%) (31.06%) (7.92%) (1.86%) 11.92% 11.81% (11.00%) (22.32%) (24.65%)
Free Cash Flow Yield
(58.55%) (58.55%) (35.25%) (7.58%) 4.92% 13.03% 6.50% (8.90%) (25.40%) (18.09%)
Revenue per Share
1.78 3.19 1.67 0.18 2.11 45.83 48.89 17.93 8.43 5.00
Operating CF per Share
1.10 (5.14) (4.08) (1.39) 5.32 33.80 12.64 (8.16) (7.82) (4.81)
Capex per Share
(0.55) (0.91) (1.30) (0.10) (0.18) (0.70) (1.02) (1.85) (2.74) (0.52)
Free Cash Flow per Share
0.55 (6.04) (5.38) (1.48) 5.14 33.09 11.63 (10.01) (10.56) (5.33)
Cash per Share
17.42 11.74 18.76 3.34 12.09 26.62 25.13 22.52 18.29 14.91
Shareholders Equity per Share
(5.51) (8.55) 18.87 3.55 6.72 35.10 48.54 36.27 28.39 22.24
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(5.51) (8.55) 18.87 3.55 6.72 35.10 48.54 36.27 28.39 22.24
Free Cash Flow
33.59 (389.88) (436.63) (491.00) 1,959.00 13,336.00 4,581.00 (3,825.00) (4,055.00) (2,075.00)
Working Capital
924.35 591.76 1,340.20 985.69 1,909.00 6,943.00 8,508.00 7,310.00 5,893.00 4,557.00
Capital Expenditures
(33.14) (58.40) (105.77) (32.00) (68.00) (284.00) (400.00) (707.00) (1,051.00) (202.00)
Net Current Asset Value
(664.82) (852.63) 1,131.10 714.19 1,522.00 5,547.00 6,696.00 5,753.00 4,858.00 2,856.00
EV/EBIT
0.00 0.00 0.69 0.00 0.00 6.94 6.53 0.00 0.00 0.00
Capex to Sales
0.31 0.28 0.78 0.53 0.08 0.02 0.02 0.10 0.32 0.10
Net Profit Margin
(212.47%) (131.10%) (297.52%) (856.67%) (93.03%) 66.06% 43.41% (68.84%) (110.04%) (145.16%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 7.70 7.49 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.22 0.16 0.11 0.13 0.14 0.23 0.19 0.29 0.04 0.07
Cash ROIC
(1.97%) (212.31%) (17.59%) (28.50%) 23.77% 48.60% 9.90% (21.98%) (28.95%) (26.61%)
Accounts Receivable Turnover
6.88 15.28 10.39 6.68 1.15 8.09 8.45 6.01 5.18 7.17
Accounts Payable Turnover
0.61 0.86 0.96 1.62 0.64 16.36 13.73 9.32 3.17 2.40
Inventory Turnover
0.00 0.00 0.00 0.00 0.01 3.52 4.53 8.15 9.18 6.43
Average Days of Payables
679.99 360.22 455.67 83.48 821.25 42.12 32.82 40.44 100.97 133.30
Days of Inventory on Hand
0.00 0.00 0.00 0.00 2,144.38 200.98 63.96 15.71 29.17 64.34
Average Receivables
15.76 13.47 13.00 8.98 698.18 2,283.00 2,280.00 1,138.50 625.00 271.00
Average Payables
24.58 24.44 25.97 19.15 12.55 160.00 394.50 503.50 462.50 361.00
Average Inventory
— — — — 744.00 744.00 1,195.00 575.50 159.50 135.00
Average Assets
1,250.58 1,250.83 1,523.32 1,775.79 4,463.21 16,003.00 25,263.50 22,142.00 16,284.00 13,240.00
Average Common Equity
(442.90) (443.09) 489.44 1,352.53 1,867.91 8,353.00 16,634.00 16,488.50 12,377.50 9,775.50

Fold the line items

Columns are period end dates